Neisseria gonorrhoeae isolated from patients with disseminated infection (DGI) often resist complement (C¢)-dependent killing by normal human serum (NHS) and less commonly by convalescent DGI serum. 7 of 10 NHS specimens completely inhibited killing of serumresistant (ser r ) gonococci by convalescent or immune DGI serum. Immunoglobulin G (IgG) purified from NHS was shown to be the blocking agent. In addition, IgM (plus C¢) purified from NHS was shown to be fivefold more effective (wt/wt) in killing serum-sensitive (ser s ) gonococci than equivalent amounts of IgM tested in the presence of IgG (whole serum).
A B S T R A C T Neisseria gonorrhoeae isolated from patients with disseminated infection (DGI) often resist complement (C')-dependent killing by normal human serum (NHS) and less commonly by convalescent DGI serum. 7 of 10 NHS specimens completely inhibited killing of serum-resistant (serr) gonococci by convalescent or immune DGI serum. Immunoglobulin G (IgG) purified from NHS was shown to be the blocking agent. In addition, IgM (plus C') purified from NHS was shown to be fivefold more effective (wt/wt) in killing serum-sensitive (sers) gonococci than equivalent amounts of IgM tested in the presence of IgG (whole serum). Although inhibition of NHS killing of sers gonococci required a 640% excess of IgG, only a 40% excess was required to block immune serum killing of serr gonococci. F(ab')2 prepared from IgG also blocked killing of serr gonococci by immune serum indicating antigenic specificity of blocking IgG.
IgG immunoconcentrated against outer membrane protein (OMP) derived from serF gonococci showed 40- fold increased blocking activity over normal IgG (wt/ wt) and lacked antibody activity directed against gonococcal lipopolysaccharide by ELISA. Using direct immunoabsorption of IgG with purified gonococcal OMP; serr_OMP was found sixfold more effective than sers-OMP in neutralizing the blocking of immune serum killing of serr gonococci, and 10-fold more effective in systems that used excess blocking IgG, NHS, and ser' gonococci. Blocking IgG preabsorbed with whole serr gonococci lost 75% of its ability to block immune serum killing compared with no loss in this system using a similar absorption with sers gonococci. IgG purified from NHS contained fivefold higher titers of antibody against serr-OMP than sers-OMP by ELISA.
INTRODUCTION
Resistance to killing by normal human serum (NHS)' and complement is exhibited by most strains of Neisseria gonorrhoeae that cause disseminated infection, (DGI) (1) . Although gonococcal lipopolysaccharides are the major target of bactericidal antibodies in human sera (2, 3) , unique outer membrane protein antigens have been identified in certain gonococcal strains that resist killing by human serum (4) ; therefore susceptibility of individual gonococci to human serum may represent a varied and complex interaction between several surface antigens of the gonococcus and the host. Strains that resist killing by normal human serum (serr strains), however, often are killed by convalescent human DGI serum (1, 5) and by normal rabbit serum (6) in complement-dependent reactions, indicating that these serr strains indeed are susceptible to lysis by bactericidal antibody and complement. Complement-dependent killing of human serr gonococci by normal rabbit serum, however, can be blocked by normal human IgG (6) . This may indicate that naturally occuring antibodies bind to the surface of gonococci and interfere with the lytic attack by bactericidal antibody and complement. The studies reported here were designed to investigate the blocking action of normal human IgG in human gonococcal bactericidal systems in order to characterize serum resistance of gonococci. We also examined the relative effect of blocking upon the killing of human serum-resistant ' Abbreviations used in this paper: BSA, bovine serum albumin; C', complement; DGI, disseminated infection; KDO, 3- and serum-sensitive strains and the corresponding antigens from these strains that were the binding sites of blocking antibody.
METHODS

Strains and serums
Isolates of N. gonorrhoeae were identified according to standard methods (7) and were stored frozen at -70°C in trypticase soy broth: glycerol (4:1, vol/vol). We used two strains: one was a serum-sensitive (sers) strain that was killed by the serum of each of 10 volunteers in dilutions of >1:100 when supplemented with an exogenous source of complement from a patient with hypogammaglobulinemia; the other was a serum-resistant (serr) strain isolated from the blood of a patient with DGI that resisted killing by the same 10 fresh normal human serum at a 2:3 dilution.
Normal human serum was the source of killing activity in experiments that used the sensitive strain, and convalescent serum from the DGI patient infected with the serr strain was the source of bactericidal activity directed against the otherwise resistant strain.
The methods of antigen and antibody preparation to be described are represented schematically in the flow diagram (Fig. 1 ).
Media and growth conditions for preparation of antigen
Transparent, nonpiliated phenotypes of gonococci were grown in mass culture in petri dishes containing a clear media of trypticase and thiotone peptones (BBL, Div. Becton, Dickinson & Co., Cockeysville, MD), plus salts and soluble starch, prepared according to the methods of James and Swanson (8) . A solution of a supplement (1%, vol/vol) identical to Isovitalex (BBL) was added to the autoclaved media after it had cooled. One loopful of thawed organisms was transferred to each of 20 plates that were then grown for 16 h in a candle extinction jar at 370C. Organisms from each plate were used to heavily inoculate 10 additional plates using cotton-tipped applicators. The 200 plates were grown for 16 h and the organisms were harvested with rubber spatulas, washed three times with 0.15 M NaCl, and checked for contamination. For radiolabeling experiments, organisms were grown in a liquid media similar to the solid media described, lacking only the agar and containing [3H] sodium acetate, according to methods we have described (3 
Separation and characterization of outer membrane antigens
Outer membranes were dissolved in a buffer containing 0.05 M glycine, 0.001 M EDTA, and 1.5% sodium deoxycholate adjusted to pH 9.0 with NaOH (NaD buffer), which has been shown to disaggregate gonococcal endotoxin (3) . Outer membrane suspensions were solubilized in this buffer by alkalinization to pH 11.0 briefly; the clear suspensions were then promptly chromatographed on a 2.6 X 35-cm column of Sephadex G-100 (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated in the NaD buffer, and 4-ml fractions were collected.
Fractions that showed absorption of ultraviolet light at 280 nm were pooled and dialyzed exhaustively against dilute NaOH (pH 9.0) at 4°C to free the preparation from NaD. Further purification was accomplished by the addition of ethanol (10%, vol/vol) to displace deoxycholate bound to protein; this was followed by terminal dialysis against 0.025 M glycine in 0.15 M NaCl adjusted to pH 9.0 with NaOH (glycine buffer). Protein antigens were concentrated, using pressure filtration (Amicon Corp., Scientific Sys. Div., Lexington, MA), and these solutions were used as stocks for subsequent experiments. Protein concentration was measured with Folin phenol reagent, using bovine serum albumin (BSA) as a standard (9) . Peptide patterns of outer membranes and proteins extracted from outer membranes were analyzed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) (10, 11 To assess the relative solubility of outer membrane proteins in glycine buffer, protein antigens were ultracentrifuged at 50,000g for 30 min and the supernatants were checked for decrease in protein concentrations (9) before their use in blocking antibody-binding experiments.
Lipopolysaccharide (LPS) was collected from later fractions (250-350 ml) of the Sephadex G-100 column (3), recovered, and purified from NaD similarly to outer membrane protein. The first dialysis, however, was carried out using mol wt 8,000 cutoff tubing (Spectrapor, Fisher Scientific Co., Pittsburgh, PA) to retain low molecular weight disaggregated LPS. A concentration of 3-deoxy-manno octulosonic acid (KDO), a constituent sugar of gonococcal LPS (5), was determined for outer membrane antigens by the thiobarbituric acid reaction, modified to compensate for the presence of excess polysaccharide (12, 13) . KDO standards (Sigma Chemical Co., St. Louis, MO) were run simultaneously, and maximum absorption was determined by scanning at several wavelengths between 500 and 600 nm.
Skin sites for testing of the dermal Shwartzman reaction were prepared in groups of five 2-to 3-mo-old New Zealand white rabbits (1.0-1.5 kg) by the intradermal injection of twofold serial dilutions of 0.25-ml samples of outer membrane antigens. The reactions were provoked 21 h later by the intravenous injection of 0.5 ml of the corresponding samples. Hemorrhage or necrosis of the skin within 6 h after the provocative dose was given was recorded as a positive reaction, and 50% endpoints were calculated (14) .
Immunoglobulin separation
IgM was separated by gel filtration (15) from serum of a volunteer that had been shown to kill the sers strain. 9 ml of the serum was applied to a 1.6 X 85-cm column containing Bio Gel A-5M (Bio-Rad Laboratories) equilibrated in 0.1 M Tris and 0.15 M NaCl buffer (pH 7.5) at 4°C. Fractions were assayed for immunoglobulin content by rate nephelometry (Beckman Instruments, Inc., Fullerton, CA) (16) . The effluent containing IgM was pooled, concentrated, and dialyzed against 0.5 M saline. Final adjustment of volume was performed (-4 ml) to approximate the concentrations of IgM in whole serum and sterilized by filtration. IgG, IgA, and IgM content of the concentrate were measured by rate nephelometry (Beckman Instruments, Inc.) with antisera directed against the three immunoglobulins (16).
IgG was separated by anion exchange chromatography (17) from the same serum after it was determined that the whole serum blocked killing of the sers strain by the convalescent serum obtained from the DGI patient (see Blocking assay). QAE-Sephadex A-50 gel was equilibrated in a 0.048-M ethylene diamine, 0.073 M acetic acid buffer (pH 7.0), then 5 ml of the serum was mixed with an equal amount of buffer and applied to a 13 X 2.6-cm column of the gel mixture. Fractions were assayed for immunoglobulin content by rate nephelometry using antisera directed against IgG (Beckman Instruments, Inc.) (16) . The effluent containing IgG was pooled, concentrated, and dialyzed against 0.15 M saline. The volume (-3 ml) was adjusted to approximate the concentration of IgG in whole serum and sterilized by filtration.
Solid phase immunoadsorption mg) was suspended in 10 ml of 0.1 M NaHCO3 buffer containing 0.5 M NaCl (pH 8.3) and gently mixed with the swollen gel mixture for 2 h at room temperature. After washing the gel with the NaHCO3 buffer, remaining active groups were blocked by reacting the gel with 1.0 M ethanolamine (pH 9.0) for 2 h at room temperature. The gel was then washed with 0.1 M acetate buffer in 1.0 M NaCl (pH 4.0), followed by 0.1 M borate buffer in 1.0 M NaCI, (pH 8.0). The gel was placed into a 0.9 X 15-cm column, equilibrated with 0.2 M borate buffer in 0.15 M NaCl, pH 9.0, (borate buffer), and washed free of protein (18) . Mock elution was performed by passing 20 ml of 2.0 M potassium iodide in borate buffer (KI buffer) through protein columns (19) . Fractions were collected and monitored for protein antigen leakage (9-11), but none was detected.
1 mlof purified IgG (450 mg/100 ml) was dialyzed against borate buffer and applied to the column. Fractions were collected until IgG was no longer detectable by rate nephelometry (16) . An additional 20-ml of buffer was collected and handled exactly as the subsequently eluted IgG, as a buffer control. 20 
Preparation of F(ab')2
Purified IgG prepared from normal human serum with blocking activity was dialyzed against 0.1 M sodium acetate, (pH 4.3), and then incubated with pepsin (Sigma Chemical Co.) at an enzyme/substrate ratio of 1:100 for 7 h at 37°C; the reaction was stopped by increasing the pH to 9.0 with a few drops of 2.0 M Tris-HCl in 1.0 M NaOH, (20 (23) . In experiments that used outer membrane proteins, 12 X 75-mm polystyrene tubes (Falcon Labware, Div. of Becton Dickinson & Co., Oxnard, CA) were coated at 37°C for 3 h with NaCO3 buffer (pH 9.6) solution of outer membrane protein (5.0 Ag/ml) derived from the two strains (24) . The 5.0-,ug/ ml outer membrane protein coat concentration was predetermined to give optimal readings (23) .
Experiments were performed in triplicate using 1.0-ml vol. After the coating the tubes were washed with 0.05% Tween-20 in phosphate-buffered saline (pH 7.4) and then reacted with normal IgG diluted in PBS-0.05%-Tween-20 for 1 h at 370C. Antihuman IgG alkaline phosphatase conjugate (y-chain specific 1:1,000) (Sigma Chemical Co.) was added after another wash and allowed to react for 1 h at 37°C. After the final wash, the substrate, disodium-p-nitrophenyl phosphate, in 0.09% diethanolamine buffer (pH 9.8) was added, and the reaction was allowed to proceed for 1 h at room temperature, and 0.2 ml of 3.0 N NaOH was added to halt the reaction; readings were performed immediately at 405 nm on a spectrophotometer (Gilford 250, Gilford Instrument Laboratories Inc., Oberlin, OH). Controls included tubes coated with outer membrane protein, and reacted with conjugate (antigen control), mock coated wells reacted with IgG and conjugate (antisera control), and mock-coated wells reacted with conjugate alone (conjugate control). Optical density of control readings were <0.1. Readings >0.2 were considered positive. Experiments that used soluble electrodialyzed triethylamine LPS salts (25) , as target antigens, were performed using a barbital-acetate coating buffer (pH 4.7) (26), and optimal coating concentrations of the serr LPS salt at 7.5 ,g/ml (27) .
Bactericidal assay
The bactericidal assay used in this study was a modification of the described procedure (28) . Reaction mixtures were performed in 12 X 75-mm capped tubes. Test mixtures contained 0.05 ml of complement, 0.075 ml of dilution of test serum or immunoglobulin fraction, and 0.025 ml of gonococci.
REAGENTS
Complement. Freshly drawn serum of an individual with acquired hypogammaglobulinemia containing IgG <20 mg/ 100 ml, IgA < 3.8 mg/100 ml, and IgM < 4.9 mg/100 ml, was allowed to clot for 15 min. The serum was separated by centrifugation at 3,000 g for 10 min at 24°C, and then immediately stored at -70°C. Total hemolytic complement activity of the serum was 125 C'H5o U/ml (N, 111±15).
Serum. DGI patient serum and a normal serum, which had been stored at -70°C, were used in a bactericidal reactions with the ser' and sers strains, respectively. Purified human serum immunoglobulin fractions were similarly examined. 
Blocking assay
Reagents. The following reagents were tested for their ability to block killing of the serr DGI strain by homologous convalescent DGI serum: (a) the 10-volunteer serums, tested individually, (b) IgG derived from normal human serum, (c) normal IgG with specific anti-serr outer membrane protein activity prepared by immunoadsorption, and (d) F(ab')2 fragments prepared from normal IgG with blocking activity. Also tested was the ability of IgG from normal human serum to block killing of the sers strain by normal human serum.
Method. Heat-inactivated (560, 30 min) normal serum, IgG preparations, or F(ab')2 fragments were diluted serially in 0.05 ml with 0.15 M saline and incubated for 15 min with diluted serr organisms (0.025 ml) at 37°C. Thereafter, 0.025 ml of a dilution of convalescent DGI serum that had produced -a 1-logl0 kill in the bactericidal assay, was added to the reaction mixture together with 0.05 ml of complement. Controls included the DGI serum plus complement to ensure an adequate killing system and other controls routinely used in the bactericidal assays. To ensure that inhibition was specific immune inhibition and not anticomplementary activity, normal serum, IgG, and F(ab')2 concentrations shown to inhibit killing of serr gonococci were added to a similarly designed complement-dependent bactericidal test that used a strain of nontypable Haemophilus influenzae and human serum that had been titered to produce a 1-logl0 kill.
We also used IgG derived from normal serum to attempt blocking of the killing reaction of diluted normal serum plus complement against the sers strain. IgG used in these experiments were purified from the same normal serum used as the source of killing antibody.
Blocking inhibition assay
Reagents. Varying concentrations of outer membrane protein and outer membrane-derived lipopolysaccharides from the two strains were used to attempt dose-related inhibition of blocking activity directed against each of the two strains.
Method. Outer membrane antigen preparations were serially diluted in 0.05 ml of glycine buffer and incubated (37°C, 15 min) with concentrations of IgG that were shown capable of complete blocking in the bactericidal assays. Thereafter, these IgG-antigen mixtures were used as the source of blocking activity, and they were incubated with organisms as described in the blocking assays. Dilutions of killing serum and complement were added to complete the reaction mixtures. Because regenerated killing was the end point in these assays, antigen controls that contained the highest concentrations of antigen used in the assays added to complement and blocker IgG were included in each experiment to ensure adequate survival of organisms in the absence of killing antibody. Absorption of IgG blocking activity also was attempted using serr and sers gonococci at IgG/organism ratios that blocked immune lysis of the serr strain. Absorption conditions duplicated those used to fix IgG to gonococci in the blocking assays. Unabsorbed IgG was recovered in the supernatants of centrifuged absorption mixtures and used in blocking assays.
RESULTS
Preparation and characterization of outer membrane antigens. Ultraviolet light absorption at 280 nm of fractions of outer membrane prepared from the sers and serr strain after passage through the Sephadex G-100 column equilibrated in the NaD buffer revealed single major protein peaks at the void volume (Fig. 2) . Nucleic acid contribution to the protein peak was estimated at <1.5% (R28o/260> 1.25). Protein antigens freed from NaD and suspended in glycine buffer were judged to be relatively dispersed by their ability to remain in solution after ultracentrifugation.
Chemical analysis of protein preparations derived from the sers and serr outer membranes revealed protein concentrations of 92 and 89%, respectively. SDS-PAGE analysis performed on the dialyzed single protein peaks from outer membranes of each of the strains recovered from Sephadex G-100 columns showed that major peptide bands present in outer membrane preparations were preserved throughout the purification procedure, although there was some loss of a few minor bands (Fig. 3) . The largest outer membrane protein bands resolved at molecular size 36,500 for serr outer membrane and its derived outer membrane protein antigen, and slightly lower for sers outer membrane antigens. Other major membrane protein bands varying in size from 27,000 to 32,000 were seen in the profiles of antigens from both strains. Outer membrane proteins showed no detectable KDO or Shwartzman activity when 750,g of each antigen was tested, indicating <0.9 and 0.8% LPS contamination of sers and serr proteins, respectively, by chemical assay, and <0.5 and 1.6% contamination by biologic assay.
LPS antigens derived from sers and serr outer membranes from later fractions of the Sephadex column showed no protein detectable (<1.0%, wt/wt) in either preparation. KDO concentrations determined for sers and serr LPS were 6.5 and 8%, respectively, and the sensitizing doses (ID50) of LPS in the dermal Shwartzman reactions were 4 and 12 pig. FIGURE 2 Elution profile of sers and serr gonococcal outer membranes on a 2.6 X 85-cm column of Sephadex G-100 equilibrated in 0.5 M glycine, 0.001 M EDTA, 1.5% sodium deoxycholate (NaD), pH 9.0 buffer. Membranes were brought up in the buffer, solubilized by increasing the pH to 11.0, neutralized to pH 9.0, applied to the column, and eluted with NaD buffer, (ultraviolet light 280 nm absorbance sers and serr_ ---membranes). Radioactivity/l ,ul [3H] for gonococci grown in the presence of 3H sodium acetate, (-----). 3H labeling of first peak not shown, 2nd peak confirmed LPS by presence of KDO. LPS peak the same for both antigens. The results of bactericidal assays using twofold serial dilutions of purified IgM and normal serum (whole IgM) are shown in Fig. 4 . No contaminating IgG (<1.5 mg/100 ml) or IgA (<3.8 mg/100 ml) was detected in the IgM preparation containing 100 mg IgM/100 ml. These experiments demonstrated that a fivefold 948000 45 000, 30 
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MF FiGURE 3 SDS PAGE of the outer membrane complex extracted from serum-sensitive (S-OM) and serum-resistant (R-OM) gonococci First peaks (Fig. 2 , Sephadex G-100 elutions) of ser (S OMP) and ser' (R-OMP) outer membrane are shown on either side of OM.
greater concentration was required for killing of the sers strain by whole serum IgM, compared with purified IgM in the complement-dependent reaction and suggested that blocking activity might be present in whole normal serum, which interferred with IgM-mediated killing of the ser' strain. Purified IgM plus complement, however, did not kill the ser' strain.
Blocking assays. 7 of the 10 volunteer serums completely blocked killing of the serr strain by immune serum and complement. Two serums partially blocked and one had no effect. IgG prepared from a blocking volunteer serum was examined for its ability to block killing of gonococci by bactericidal antibody and complement. No contaminating IgM (<4.9 mg/100 ml) or IgA (<3.8 mg/100 ml) was detected in IgG preparation containing 900 mg IgG/100 ml. These purified IgG fractions (plus complement) used in concentrations equaling those present in normal sera were shown incapable of killing either strain in the bactericidal assay.
The results of the experiments demonstrating the blocking effects of purified IgG upon bactericidal activity are demonstrated in Fig. 5 . These experiments used the preincubation of serial dilutions of the IgG preparation with serr organisms before the addition of serum from the patient with DGI, and complement. Also Blocking inhibition. To examine the role of gonococcal antigens in the recognition and binding of IgGblocking antibodies, we used both outer membrane proteins and lipopolysaccharides as absorbants for blocking IgG; however, we reasoned that outer membrane proteins might be the primary target of the blocking antibodies because lipopolysaccharide antigens have been shown to be the major target of gonococcal bactericidal antibodies (2, 3) . In preliminary experiments, we measured IgG antibody concentrations directed against both sers and serr outer membrane proteins in normal serum and purified normal IgG, by ELISA. The titer against serr OMP was 1:500, fivefold greater than the 1:100 titer against sers outer membrane protein. We also tested blocking activity of purified IgG that had been absorbed to and subsequently eluted from serr outer membrane protein that had been affixed to the immunoabsorbant column. The adsorbed IgG preparation with a measured IgG concentration of 11 mg/100 ml showed a 40- Direct absorption experiments with outer membrane protein antigens and blocking IgG were performed to examine a dose-response effect of antigen absorption and to compare the relative blocking efficacy of these two different outer membrane antigen preparations. LPS antigens also were tested in these assays. t Fig. 6 illustrates experiments where increasing concentrations of proteins prepared from the serr and sers strains were used to absorb blocking dilutions of IgG before preincubation with organisms. A comparison of concentrations of the two antigens revealed that a fivefold lower concentration of ser' protein was needed to inhibit the blocking action of IgG, compared with the sers protein. A similar experiment performed with normal serum and the sers strain showed that the serr (heterologous) protein inhibited blocking IgG at a 10-fold lower concentration than sers protein (Fig. 7) . Protein antigen concentrations used in both experiments displayed no toxicity to the organism when used Serum-resistance of Neisseria gonorrhoeae 163 (29, 30) and Haemophilus influenzae (31) . Currently the role of complementdependent serum bactericidal activity in the host defense against the three major categories of gonococcal infection; uncomplicated, locally invasive (i.e., pelvic inflammatory disease in women), and bacteremic infection is incompletely defined. Although serum bactericidal activity directed against gonococci that cause uncomplicated local infection does not appear to protect against this disease, its absence in women with pelvic inflammatory disease infected with gonococci otherwise sensitive to normal human serum may indicate susceptibility to locally invasive strains in these women (28) . Moreover, resistance to the lytic action of normal human sera of most strains that cause bacteremic infection may prove to be an important factor that enables these strains to invade, disseminate, and produce distinct manifestations of the disseminated syndrome (32) .
The complex interaction between the surface antigens of gonococci jug Antigen mg (blocking) IgG FIGURE 7 Concentrations of antigens per milligram of blocking IgG used to inhibit the blocking effect and regenerate the normal human serum killing system directed against the sers strain: increasing concentrations of serr outer membrane protein used to absorb blocking IgG before blocking assay was performed (----) and the same experiments with ser' outer membrane protein ( ), serr LPS (A), and ser' LPS (V); n = 2±range. sion to human buccal epithelial cells (36) , and serumresistance (in at least one strain) (37) . These proteins are heat-modifiable (38, 39) and can be distinguished from a third outer membrane protein (protein 3), which although not modifiable by heat, can be modified by chemical reduction from a protein that migrates on SDS-PAGE with an apparent molecular weight of 30,000 to one of higher molecular weight (38, 40) . In our studies we prepared antigens derived from gonococcal outer membranes, containing these and other proteins to investigate the role of these antigens, separate from lipopolysaccharides, in serum resistance of gonococci. Although protein 1 is only partially soluble in sodium deoxycholate at pH < 8.5 (38, 41, 42) we used brief alkalinization of outer membranes to pH 11.0 in sodium deoxycholate and EDTA followed by chromatographic separation of proteins from LPS and subsequent suspension of proteins at pH 9.0 in glycine buffer to permit relative solubilization.
That differences in cell surface structure of sers and serr strains may be important in explaining serum resistance is reflected perhaps by the different human immunoglobulin classes responsible for the killing of gonococci. "Natural" bactericidal activity against serum-sensitive gonococci has been shown here and by others to be mediated by IgM (43) ; however, the killing of strains resistant to normal human serum is accomplished by IgG isolated from convalescent DGI sera, which is directed also against lipopolysaccharide antigens (3). These isolated immune IgG fractions often are capable of killing heterologous DGI strains but not serP strains (unpublished observations), suggesting that cross reactive antigens shared by DGI strains may include common lipopolysaccharide determinants in addition to outer membrane proteins. However, in these studies, we have shown that normal IgG may interfere with natural as well as immune serum killing of both sers and serr gonococci, respectively. This blocking activity occurred via the F(ab')2 portion of the IgG molecule and was dependent upon light chain concentration, indicating, therefore, that blocking antibodies recognize specific antigenic targets (33) . Although seemingly paradoxical that a single immunoglobulin class may both kill (immune IgG) and block killing (normal IgG) of gonococci, perhaps IgG subelass specifity for different antigenic targets (44, 45) with a variable ability to activate complement (46), dictates whether killing or blocking will supervene. The added observation that bactericidal antibody development in patients convalescing from DGI is often nonexistent or meager (32) despite high titered antibody rises measured by indirect immunofluorescence (47) , suggests that blocking antibodies also may result from specific antigenic challenge. IgG also has been shown capable of inhibiting the killing of other gram-negative bacteria (48) (49) (50) in addition to Neisseria gonorrhoeae (6) . Convalescent sera from patients infected with Neisseria meningitidis may show diminished bactericidal activity against the infecting strain of the meningococcus and also may inhibit killing of meningococci by sera from normal humans (51) . Furthermore, sera taken from patients early in the course of meningococcal disease may have lytic activity against the infecting strain that is unmasked only when the sera have been freed of IgA (51) (52) . Similar inhibition also has been demonstrated in the sera of patients chronically infected with common enteric gram-negative bacilli and in the IgA fractions of sera taken from patients with chronic brucellosis (53) .
Although we have shown that killing of gonococci can be blocked by human IgG antibodies, greater blocking efficacy of IgG against serr vs. ser' strains and possibly higher titers of natural IgG against ser' proteins measured by direct binding assays suggest that quantitative differences in blocking antibodies attaching to serr gonococci may contribute to impaired access of lytic antibody and complement to lipopolysaccharide targets due to steric hindrance. Antigenic differences in the outer membrane proteins of strains also may be important in the recognition and avidity of natural blocking antibodies. Neutralization of standardized blocking concentrations of IgG by lower concentrations of ser' vs. ser' outer membrane protein antigens for sensitive as well as resistant gonococci indicates, however, that the antigens are cross-reactive. Perhaps the location of proteins in the outer membrane and therefore the accessibility of these antigens to blocking antibodies may combine with intrinsic antigenicity as additional important factors. Surface labeling of whole gonococci with 125I using the lactoperoxidase method labels proteins 1 and 2 (38, 54) , although the efficiency of protein 2-labeling using this method may vary (24) , suggesting limited association of this protein with the outer surface membrane (38) . Protein 3 has been shown to be positioned near protein 1 in the outer membrane by demonstrating cross-linking of these two proteins when vesicles of outer membrane are treated with protein cross-linking reagents (39) . The specific targets of blocking antibodies are yet unknown, however, the exposure of the protein antigen receptors at the surface of the gonococcus may be an important factor in recognition of gonococci by these antibodies.
